Clinical trial · Observational
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
Treatment Patterns and Outcomes in Patients With Advanced Melanoma: A Retrospective Study Using Data From the German ADOREG Registry
NCT05426239CI-TRIAL-00059176completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a non-interventional retrospective observational study performed on secondary data from a German multi-site cohort registry, the German national registry of skin cancer (ADOReg).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Melanoma | Melanoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Cohort 1
- description
- Participants initiating first-line systemic therapy to treat advanced melanoma.
Primary outcomes (1)
- measure
- Overall Survival (OS)
- timeFrame
- Up to a maximum of 4 years of follow-up
Secondary outcomes (9)
- measure
- Progression-Free Survival (PFS)
- timeFrame
- Up to a maximum of 4 years of follow-up
- measure
- Objective Response Rate (ORR)
- timeFrame
- Up to a maximum of 4 years of follow-up
- measure
- Duration of Response (DOR)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Signed informed consent for inclusion in ADOReg registry must be documented at study site * Diagnosis of advanced (nonresectable or metastatic) melanoma in stage III or stage IV * Participants received any systemic therapy to treat the advanced melanoma * First-line systemic treatment was initiated within the index window (19-Jun-2015 to 30-Jun-2018) Exclusion Criteria: * Age \<18 years at index date * Receipt of clinical trial study drug at any time
References
Publications (0)
Data not yet available
No reference posted for this study.